StriVectin

Transaction overview

Status: Announced

Exact closing date not established.

Crown Laboratories, identified as a portfolio company of Hildred Capital Management LLC, announced on August 26, 2021 that it had agreed to acquire StriVectin from L Catterton. Completion remained subject to regulatory approvals and customary closing conditions. The expected September closing was a forecast; this source does not establish an actual closing date. Transaction terms were not disclosed.

Selected source-supported transactions; coverage is incomplete. Announcements do not establish completion or that a deal is still pending. Sponsor activity and operating-business transactions are distinct from adviser acquisitions. Unclassified activity is excluded from adviser-only counts.